Reply
We reported that coronary calcium and C-reactive protein (CRP) contribute independently to predicting cardiovascular events. Hecht, Rumberger, and Budoff use a specific brand of CT scanner (GE Imatron) and appear offended by unintended implications in our report. Our purpose was not to compare an inexpensive laboratory test with a costly radiographic measurement but rather to report that two manifestations of risk contribute independently to future heart disease. Coronary calcium is a surrogate marker, whereas CRP provides an assessment of atherosclerotic activity.
The specific criticisms: Statistics. Our critics imply that our conclusions are based on "marginally significant results" relating CRP to future myocardial infarction coronary death (Pϭ0.07 and 0.09), They overlook the additional significant (PϽ0.05) results:
• Significantly larger CRP values for those with end points (Pϭ0.002).
• CRP was a significant predictor of any cardiovascular event (Pϭ0.03).
• After adjusting for the risk factors and calcium, CRP still contributed to predicting any event (Pϭ0.02).
• Compared with the low-risk CRP/calcium group, there was increasing risk for events with increasing CRP and calcium (PϽ0.001).
Furthermore, we are not changing our "predetermined level of significance" but rather using recommended procedures for reporting both statistically significant (PϽ0.05) and marginally significant (0.05ϽPϽ0.10) results. There is nothing "magical" about the cutoff of 0.05, and we are ethically responsible for reporting results that are close to the 0.05 level.
Scanner Brand. Hecht et al are concerned that we did not give sufficient recognition to the brand of CT scanner used in our study and in their commercial screening ventures (GE Imatron EBT). There are several scanner models available that produce results with calcium scores that have the same or improved accuracy when compared with the EBT brand. 1-3 It would not be appropriate to name the brand of a diagnostic instrument every time we refer to it unless there is proof that a particular brand is superior to others. In this case, there is no such proof.
Intermediate Versus High Risk. Hecht et al imply that our results may not apply to adults at intermediate coronary heart disease risk. By substituting risk factor levels measured in our cohort into the Framingham risk algorithm, 4 we find the mean 10-year coronary heart disease risk to be 19.8% at baseline, which is within the intermediate risk definition according to the National Cholesterol Education Program. 4 We therefore stand by our characterization of this cohort as "intermediate" in risk.
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